Literature DB >> 33881723

Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.

Shereen Shi Min Lai1, Khuen Yen Ng2, Rhun Yian Koh3, Kian Chung Chok1, Soi Moi Chye4.   

Abstract

The endosomal-lysosomal system mediates the process of protein degradation through endocytic pathway. This system consists of early endosomes, late endosomes, recycling endosomes and lysosomes. Each component in the endosomal-lysosomal system plays individual crucial role and they work concordantly to ensure protein degradation can be carried out functionally. Dysregulation in the endosomal-lysosomal system can contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). In AD endosomal-lysosomal abnormalities are the earliest pathological features to note and hence it is important to understand the involvement of endosomal-lysosomal dysfunction in the pathogenesis of AD. In-depth understanding of this dysfunction can allow development of new therapeutic intervention to prevent and treat AD.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer's disease; Endosomal‐lysosomal system; Endosome trafficking; Lysosomal defects; Neurodegeneration; Pathogenesis; Therapeutic interventions

Mesh:

Year:  2021        PMID: 33881723     DOI: 10.1007/s11011-021-00737-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  122 in total

1.  Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease.

Authors:  E Adamec; P S Mohan; A M Cataldo; J P Vonsattel; R A Nixon
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 2.  Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions.

Authors:  Sandrine Andrieu; Nicola Coley; Simon Lovestone; Paul S Aisen; Bruno Vellas
Journal:  Lancet Neurol       Date:  2015-07-23       Impact factor: 44.182

3.  Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system.

Authors:  Claudia G Almeida; Reisuke H Takahashi; Gunnar K Gouras
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

4.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

Review 5.  Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?

Authors:  Andrew J Beel; Masayoshi Sakakura; Paul J Barrett; Charles R Sanders
Journal:  Biochim Biophys Acta       Date:  2010-03-18

6.  Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?

Authors:  Andrew J Beel; Charles K Mobley; Hak Jun Kim; Fang Tian; Arina Hadziselimovic; Bing Jap; James H Prestegard; Charles R Sanders
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

7.  Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.

Authors:  Paul A Adlard; Robert A Cherny; David I Finkelstein; Elisabeth Gautier; Elysia Robb; Mikhalina Cortes; Irene Volitakis; Xiang Liu; Jeffrey P Smith; Keyla Perez; Katrina Laughton; Qiao-Xin Li; Susan A Charman; Joseph A Nicolazzo; Simon Wilkins; Karolina Deleva; Toni Lynch; Gaik Kok; Craig W Ritchie; Rudolph E Tanzi; Roberto Cappai; Colin L Masters; Kevin J Barnham; Ashley I Bush
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

Review 8.  Cathepsin D--many functions of one aspartic protease.

Authors:  Petr Benes; Vaclav Vetvicka; Martin Fusek
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-08       Impact factor: 6.312

Review 9.  The role of astroglia in neuroprotection.

Authors:  Mireille Bélanger; Pierre J Magistretti
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 10.  Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Authors:  Prashant R Bharadwaj; Ashok K Dubey; Colin L Masters; Ralph N Martins; Ian G Macreadie
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more
  2 in total

Review 1.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.

Authors:  Zhiqiang Deng; Yu Dong; Xiaoting Zhou; Jia-Hong Lu; Zhenyu Yue
Journal:  Acta Pharm Sin B       Date:  2021-12-18       Impact factor: 14.903

2.  Chronic Ethanol Causes Persistent Increases in Alzheimer's Tau Pathology in Female 3xTg-AD Mice: A Potential Role for Lysosomal Impairment.

Authors:  Autumn E Tucker; Coral Del Mar Alicea Pauneto; Alexandra M Barnett; Leon G Coleman
Journal:  Front Behav Neurosci       Date:  2022-05-11       Impact factor: 3.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.